SENEXON is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Medsource Pharmaceuticals. The primary component is Sennosides A And B.
Product ID | 45865-483_718c3ca4-cb96-432e-e053-2a95a90a8130 |
NDC | 45865-483 |
Product Type | Human Otc Drug |
Proprietary Name | SENEXON |
Generic Name | Senna |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2006-02-09 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Labeler Name | Medsource Pharmaceuticals |
Substance Name | SENNOSIDES A AND B |
Active Ingredient Strength | 9 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part334 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-01-01 |
Ingredient | Strength |
---|---|
SENNOSIDES A AND B | 8.6 mg/1 |
SPL SET ID: | 718c3ca4-cb95-432e-e053-2a95a90a8130 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0536-1000 | Senexon | Sennosides A and B |
0536-1275 | Senexon | Standardized Senna Concentrate |
0536-5904 | SENEXON | SENNA |
17856-1000 | Senexon | Sennosides A and B |
45865-483 | SENEXON | SENNA |
71610-058 | SENEXON | SENNA |
0536-1138 | SENNA | SENNA |
0615-7923 | SENNA | SENNA |
0904-6434 | SENNA | SENNA |
15631-0401 | SENNA | SENNA |
17856-8237 | SENNA | SENNA |
45865-624 | SENNA | SENNA |
61919-425 | SENNA | SENNA |
65437-087 | SENNA | SENNA |
67046-677 | SENNA | SENNA |
71399-8237 | SENNA | SENNA |
71610-054 | SENNA | SENNA |
43063-838 | Senna Laxative | Senna |
16103-363 | Senna Tabs | Senna |
17856-0363 | Senna Tabs | Senna |
67046-444 | Senna Tabs | Senna |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SENEXON 76006874 2442626 Live/Registered |
THE HARVARD DRUG GROUP, L.L.C. 2000-03-22 |